Elevated levels of mitochonrial respiratory complexes activities and ATP production in 17-β-estradiol-induced prolactin-secretory tumor cells in male rats are inhibited by melatonin in vivo and in vitro

Chinese Medical Journal

Volumn 126, Issue 24, 2013, Pages 4724-4730

  Wang, Bao Qiang ^a   Yang, Quan Hui ^b   Xu, Rong Kun ^c   Xu, Jian Ning ^d  

^a Beijing Shijingshan Hospital ^*  (China)

^b CANCER HOSPITAL   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Apoptosis; Melatonin; Mitochondrial function; Prolactinoma

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; ESTRADIOL; MELATONIN; MULTIENZYME COMPLEX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CARCINOGENESIS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FLUOROMETER; HYPOPHYSIS; MALE; NONHUMAN; PROLACTIN SECRETING CELL; PROLACTINOMA; RAT; SILICONE PROSTHESIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ESTRADIOL; MALE; MELATONIN; MITOCHONDRIA; PROLACTIN; PROLACTINOMA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84890348781     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131965     Document Type: Article

References (62)

1. Malpaux B, Migaud M, Tricoire H, Chemineau P. Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin. J Biol Rhythms 2001; 16: 336-347.
2. Pevet P, Bothorel B, Slotten H, Saboureau M. The chronobiotic properties of melatonin. Cell Tissue Res 2002; 309: 183-191.
3. Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res 2010; 181: 127-151.
4. Cohen M, Lippman M, Chabner B. Role of pineal gland in aetiology and treatment of breast cancer. Lancet 1978; 2: 814-816.
5. Lissoni P, Mainini E, Rovelli F, Mazzi C, Ardizzoia A, Gelosa M, et al. A clinical study of the pineal hormone melatonin in patients with growth hormone or prolactin secreting pituitary tumours. Eur J Med 1992; 1: 407-410.
6. Cutando A, López-Valverde A, Arias-Santiago S, DE Vicente J, DE Diego RG. Role ofmelatoninin cancer treatment. Anticancer Res 2012; 32: 2747-2753.
7. Reiter RJ, Tan DX, Korkmaz A, Erren TC, Piekarski C, Tamura H, et al. Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. Crit Rev Oncog 2007; 13: 303-328.
8. Casado-Zapico S, Martín V, García-Santos G, Rodríguez-Blanco J, Sánchez-Sánchez AM, Luño E, et al. Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients. J Pineal Res 2011; 50: 345-355.
9. Cho SY, Lee HJ, Jeong SJ, Lee HJ, Kim HS, Chen CY, et al. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells. J Pineal Res 2011; 51: 87-93.
10. Um HJ, Park JW, Kwon TK. Melatonin sensitizes Caki renal cancer cells to kahweol-induced apoptosis through CHOP-mediated up-regulation of PUMA. J Pineal Res 2011; 50: 359-366.
11. Gonzalez A, del Castillo-Vaquero A, Miro-Moran A, Tapia JA, Salido GM. Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology. J Pineal Res 2011; 50: 250-260.
12. Proietti S, Cucina A, D'Anselmi F, Dinicola S, Pasqualato A, Lisi E, Bizzarri M. Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells. J Pineal Res 2011; 50: 150-158.
13. Jung-Hynes B, Schmit TL, Reagan-Shaw SR, Siddiqui IA, Mukhtar H, Ahmad N. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. J Pineal Res 2011; 50: 140-149.
14. Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester L, Reiter RJ. Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem 2010; 17: 4462-4481.
15. Leja-Szpak A, Jaworek J, Pierzchalski P, Reiter RJ. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res 2010; 49: 248-255.
16. Padillo FJ, Ruiz-Rabelo JF, Cruz A, Perea MD, Tasset I, Montilla P, et al. Melatonin and celecoxib improve the outcomes in hamsters with experimental pancreatic cancer. J Pineal Res 2010; 49: 264-270.
17. Fischer TW, Zmijewski MA, Zbytek B, Sweatman TW, Slominski RM, Wortsman J, et al. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol 2006; 29: 665-672.
18. Cabrera J, Negrín G, Estévez F, Loro J, Reiter RJ, Quintana J. Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells. J Pineal Res 2010; 49: 45-54.
19. Park SY, Jang WJ, Yi EY, Jang JY, Jung Y, Jeong JW, et al. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res 2010; 48: 178-184.
20. Casado-Zapico S, Rodriguez-Blanco J, García-Santos G, Martín V, Sánchez-Sánchez AM, Antolín I, et al. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway. J Pineal Res 2010; 48: 72-80.
21. Chang TK, Chen J, Yang G, Yeung EY. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin. J Pineal Res 2010; 48: 55-64.
22. Wisessmith W, Phansuwan-Pujito P, Govitrapong P, Chetsawang B. Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells. J Pineal Res 2009; 46: 433-440.
23. Molis T, Walters M, Hill S. Melatonin modulation of estrogen-receptor expression in mcf-7 human breast-cancer cells. Int J Oncol 1993; 3: 687-694.
24. Yang QH, Xu JN, Xu RK, Pang SF. Inhibitory effects of melatonin on the growth of pituitary prolactin-secreting tumor in rats. J Pineal Res 2006; 40: 230-235.
25. Yang QH, Xu JN, Xu RK, Pang SF. Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro. J Pineal Res 2007; 42: 172-179.
26. Ebner D, Rödel G, Pavenstaedt I, Haferkamp O. Functional and molecular analysis of mitochondria in thyroid oncocytoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 60: 139-144.
27. Dumas JF, Goupille C, Julienne CM, Pinault M, Chevalier S, Bougnoux P, et al. Efficiency of oxidative phosphorylation in liver mitochondria is decreased in a rat model of peritoneal carcinosis. J Hepatol 2011; 54: 320-327.
28. Feng Z, Levine AJ. The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol 2010; 20: 427-434.
29. Raza H, John A, Brown EM, Benedict S, Kambal A. Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells. Toxicol Appl Pharmacol 2008; 226: 161-168.
30. Scott AE, Cosma GN, Frank AA, Wells RL, Gardner HS Jr. Disruption of mitochondrial respiration by melatonin in MCF-7 cells. Toxicol Appl Pharmacol 2001; 171: 149-156.
31. McClintock DS, Santore MT, Lee VY, Brunelle J, Budinger GR, Zong WX, et al. Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol 2002; 22: 94-104.
32. van der Toorn M, Slebos DJ, de Bruin HG, Leuvenink HG, Bakker SJ, Gans RO, et al. Cigarette smoke-induced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1211-L1218.
33. Dong LF, Low P, Dyason JC, Wang XF, Prochazka L, Witting PK, et al. Alpha-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II. Oncogene 2008; 27: 4324-4335.
34. Scatena R, Bottoni P, Botta G, Martorana GE, Giardina B. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am J Physiol Cell Physiol 2007; 293: C12-C21.
35. Burns G, Sarkar DK. Transforming growth factor-β1-like immunoreactivity in the pituitary gland on the rat: effect of estrogen. Endocrinology 1993; 133: 1444-1449.
36. Xu RK, Guo CH, Huang MY, Han XS, Zhou YZ, Shan HM, et al. Induction of rat prolactinoma by 17-β-estradial and its relation to expression of c-myc oncogene. Basic Clin Med 1993; 13: 29-31.
37. Shan HM, Huang MY, Wang Y. Nonradioactive in situ hybridization of cells in vitro. Basic Med Sci Clin 1995; 15: 393-396.
38. Sims NR. Selective impairment of respiration in mitochondria isolated from brain subregions following transient forebrain ischemia in the rat. J Neurochem 1991; 56: 1836-1844.
39. Bogenhagen D, Clayton DA. The number of mitochondrial deoxyribonucleic acid genomes in mouse L and human HeLa cells. Quantitative isolation of mitochondrial deoxyribonucleic acid. J Biol Chem 1974; 249: 7991-7995.
40. Veitch K, Hombroeckx A, Caucheteux D, Pouleur H, Hue L. Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damage. Biochem J 1992; 281: 709-721.
41. Krahenbuhl S, Chang M, Brass EP, Hoppel CL. Decreased activities of ubiquinol: ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c: oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin [c-lactam]-induced methylmalonic aciduria. J Biol Chem 1991; 266: 20998-21003.
42. De Cristobal J, Moro MA, Davalos A, Castillo J, Leza JC, Camarero J, et al. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats. J Neurochem 2001; 79: 456-459.
43. Stankov K, Biondi A, D'Aurelio M, Gasparre G, Falasca A, Romeo G, et al. Mitochondrial activities of a cell line derived from thyroid Hürthle cell tumors. Thyroid 2006; 16: 325-331.
44. Simonnet H, Alazard N, Pfeiffer K, Gallou C, Béroud C, Demont J, et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 2002; 23: 759-768.
45. Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, et al. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 2011; 10: 4047-4064.
46. Newmeyer DD, Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003; 112: 481-490.
47. +-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene 2002; 21: 8149-8157.
48. Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 2004; 30: 121-138.
49. Coe KJ, Jia Y, Ho HK, Rademacher P, Bammler TK, Beyer RP, et al. Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening. Chem Res Toxicol 2007; 20: 1277-1290.
50. McGill A, Frank A, Emmett N, Turnbull DM, Birch-Machin MA, Reynolds NJ. The anti-psoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria. FASEB J 2005; 19: 1012-1014.
51. Zhang HM, Zhang Y, Zhang BX. The role of mitochondrial complex III in melatonin-induced ROS production in cultured mesangial cells. J Pineal Res 2011; 50: 78-82.
52. Krahenbuhl S. Mitochondria: important target for drug toxicity? J Hepatol 2001; 34: 334-336.
53. Saraste M. Oxidative phosphorylation at the fin de siècle. Science 1999; 283: 1488-1493.
54. Halestrap A. Biochemistry: a pore way to die. Nature 2005; 434: 578-579.
55. Leist M, Single B, Castoldi AF, Kühnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185: 1481-1486.
56. Ghosh A, Bera S, Ghosal S, Ray S, Basu A, Ray M. Differential inhibition/inactivation of mitochondrial complex I implicates its alteration in malignant cells. Biochemistry (Mosc) 2011; 76: 1051-1060.
57. Okatani Y, Wakatsuki A, Reiter RJ, Miyahara Y. Acutely administered melatonin restores hepatic mitochondrial physiology in old mice. Int J Biochem Cell Biol 2003; 35: 367-375.
58. Carretero M, Escames G, López LC, Venegas C, Dayoub JC, García L, et al. Long-term melatonin administration protects brain mitochondria from aging. J Pineal Res 2009; 47: 192-200.
59. Rodríguez MI, Carretero M, Escames G, López LC, Maldonado MD, Tan DX, et al. Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated mice. Free Radic Res 2007; 41: 15-24.
60. Rodríguez MI, Escames G, López LC, López A, García JA, Ortiz F, et al. Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp Gerontol 2008; 43: 749-756.
61. Leon J, Acuña-Castroviejo D, Sainz RM, Mayo JC, Tan DX, Reiter RJ. Melatonin and mitochondrial function. Life Sci 2004; 75: 765-790.
62. León J, Acuña-Castroviejo D, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38: 1-9.